Rager's Page

[Rager]

lol...looks like that black petey guy..and he got $700,000
to pump it up.

[100lbStriper]

Check out the latest in spam !!
http://www.investorshub.com/boards/read_msg.asp?message_id=20029875

[Rager]

Well lets hope we get...
a lil energy back in penny land before the summer dulldrums hit.

[rlangmaid]

I am just starting to look at stocks again

[Rager]

GNLM - General Metals Corp Amends Record Date for 11:10 Forward Split until June 29, 2007 and Awaits Bond Approval for Start of Drilling at Independence Mine
May 29, 2007 8:06:00 AM
Copyright Business Wire 2007
RENO, Nev.--(BUSINESS WIRE)--

General Metals Corporation (OTCBB:GNLM) (FWB:GMQ): On May 10, 2007, the Company announced that it has set a record date of May 22, 2007, for its upcoming annual and special general meeting of shareholders scheduled to be held on June 29, 2007, in Reno, Nevada. A 14(a) proxy statement will be sent to shareholders of record.

The Company also previously set the record date of May 22, 2007, for shareholders of record to participate in the proposed 11:10 forward stock split, which is anticipated to be approved at the annual and special general meeting scheduled for June 29, 2007. The effective date of the forward split will be shortly after its anticipated approval at the annual and special general meeting. Therefore, the Board has resolved that the new record date for the 11:10 forward split will be June 29, 2007, after receiving the anticipated shareholder approval at the meeting.

This new date allows for the interested European investors who will be being contacted on the Company's trip to Germany in mid June and our presentation at the London Stock Exchange on June 22, 2007, to participate.

The Company has been fortunate to have raised an additional $400,000 or so by way of Private Placement, Warrant exercise and debt conversion. An 8-K will be filed accordingly. As a result of receipt of this additional funding, we have now successfully raised over 50% of the Phase 1 drilling and exploration budget of $1,350,000 and are prepared to commence the first 2 stages of the Phase 1 Program. We await reclamation bond agreement from the Bureau of Land Management so we may post the required bond and commence drilling. As previously announced, the initial drill hole sites have been located.

Company Advisory Board Member Robert Carrington, P.Geol, says: "We will start drilling around the old Independence Mine workings in our Independence Shallow Target. This is the main host of the estimated 235,000 oz. gold and 2,500,000 oz. silver, and will be developed in four stages, setting the stage for commencement of open pit mining once a suitable mine model is developed. We anticipate the drilling will be complete by mid August, 2007, and are currently preparing private land to the south of the claims to house the proposed heap leach operations."

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding the actual date of the annual and special general meeting, the approval of the forward stock split, the exploration budget and any additional funding with respect to the Phase I drilling program, the receipt of the Reclamation Bond Agreement from the Bureau of Land Management, the existence of an estimated 235,000 oz. gold and 2,5000,000 oz. silver that may be contained and developed in the Independence Shallow Target and the completion of drilling by mid-August 2007.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration. We are not in control of metals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2006 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Source: General Metals Corporation



----------------------------------------------
General Metals Corporation
Steve Parent
President & CEO
775-686-6078
Cell: 775-721-6428
[e-mail]
or
European contact:
Aspen Agency Limited
+011-44-870-479-3351
[e-mail]

[Rager]

AAGH - Asia Global Holdings Corporation Subsidiary China Media Power (CMP) to Shoot 'Who Wants To Be A Millionaire?' TV Pilot for China TV Market on June 12 in Guangzhou.
May 29, 2007 8:00:00 AM
LOS ANGELES, May 29 /PRNewswire-FirstCall/ -- Asia Global Holdings Corporation (OTC Bulletin Board: AAGH) has announced that its subsidiary, China Media Power (CMP) will begin shooting the TV pilot for "Who Wants To Be A Millionaire?" for the China TV market in Guangzhou China beginning on June 12, 2007.

CMP has set up studio facilities in Guangzhou where it plans to produce a minimum of 104 episodes of the globally successful "Who Wants To Be A Millionaire?" TV show for broadcast in China. The Company will complete final studio improvements at the end of May. A finished pilot is expected on June 15, 2007.

CMP, a 60% owned subsidiary of Asia Global Holdings Corp, entered into agreement in December 2006 with Celador International Limited, now part of 2waytraffic, to produce a minimum of 104 episodes of "Who Wants to Be A Millionaire?" for broadcast nationwide in China.

CMP parent company Asia Global Holdings Corp develops businesses and projects with proven potential and management in China.

About Asia Global Holdings Corporation

Asia Global Holdings Corporation (OTC Bulletin Board: AAGH) has a strong focus on building business in China and other emerging regions and markets in Asia and Worldwide. The company's present subsidiaries participate in media & advertising, marketing services and TV entertainment. The Company has offices in the US, Hong Kong and China.

Asia Global Holdings Corporation Website:
http://www.asiaglobalholdings.com

Forward-looking statements in this document are not historical fact as "forward-looking statements" as that term is defined in the Private Securities Litigation Reform of 1995. Forward-Looking statements are not guarantees of future performance. Our Forward -Looking statements are based on trends we anticipate in our industry and our good faith estimate on the effect on these trends of such factors as industry capacity, product demand, and product pricing. These statements are also subject to risks and uncertainties beyond our reasonable control that could cause of actual business and results of operations, to differ materially from those reflected in our forward looking statements. You may find all other information about Asia Global Holdings Corporation on the Securities Exchange Commission website, http://WWW.SEC.GOV.

SOURCE Asia Global Holdings Corporation



----------------------------------------------
Asia Global Holdings Corporation Investor Relations
[phone]
[e-mail]

[Rager]

CBRP - Cambridge Resources Releases Statement Regarding the Ontario Securities Commissions Temporary Order, Notice and Hearing
May 25, 2007 2:05:00 PM
NEW YORK, NY -- (MARKET WIRE) -- 05/25/07 -- Cambridge Resources Corporation (PINKSHEETS: CBRP) (FRANKFURT: M3F) released a statement today pertaining to a recent notice by the Ontario Securities Commission, which refers to the company's former transfer agent, Select American Transfer.

The Ontario Securities Commission issued a temporary order under section 127(1) and (5) of the Ontario Securities Commission, whereby the temporary order enforces a stop trading order to the following individuals and companies: Jason Wong, David Watson, Nathan Rogers, Amy Giles, John Sparrow, Kervin Findley, Leasesmart, Advance Growing Systems, Pharm Control, The Bighub, Universal Seismic, Pocketop, Asia Telecom, International Energy, Cambridge Resources, NutriOne Corporation and Select American Transfer.

Cambridge Resources, its Officers, Directors and Affiliates have not received notice by the Ontario Securities Commission nor any other authorities and are not and have not been involved in any of the alleged activities. In addition, Cambridge Resources has changed its transfer agent to Fairross Stock Transfer Company and has fully audited the records held with Fairross Stock Transfer and said audit was satisfactory.

Cambridge Resources, its Officers, Directors and Affiliates will cooperate fully with the investigation and hearing of the Ontario Securities Commission.

The closing of the financing may be delayed until conclusion of the investigation and hearing of the Ontario Securities Commission.

Important Information About Forward-Looking Statements

All statements in this news release that are other than statements of historical facts are forward-looking statements, which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties. We have attempted to identify any forward-looking statements by using words such as "anticipates," "believes," "could," "expects," "intends," "may," "should" and other similar expressions. Although we believe that the expectations reflected in all of our forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. A number of factors may affect our future results and may cause those results to differ materially from those indicated in any forward-looking statements made by us or on our behalf. Such factors include our limited operating history; our need for significant capital to finance internal growth as well as strategic acquisitions; our ability to attract and retain key employees and strategic partners; our ability to achieve and maintain profitability; fluctuations in the trading price and volume of our stock; competition from other providers of similar products and services; and other unanticipated future events and conditions.

Contact:
Alex Barta
Investor Relations
514-991-2272
[e-mail]

[Rager]

NVRS to NVAR to FXPE

13:56 01/11/2007 NVRS Nova Resources, Inc. Common Stock NVAR Nova Resources, Inc. New Common Stock 6-1 F/S; Payable upon Surrender of Certificates

13:37 02/05/2007 NVAR Nova Resources, Inc. New Common Stock FXPE Fox Petroleum Inc. Common Stock **

Fox Petroleum Signs $8 Million Financing Agreement
May 25, 2007 12:21:00 PM
Copyright Business Wire 2007
LONDON--(BUSINESS WIRE)--

Fox Petroleum Inc. (NASD OTC BB: FXPE) (hereafter "FOX") has signed an $8,000,000 financing agreement with Swiss based investor, EuroEnergy Growth Capital S.A. The financing agreement is an equity investment and does not include any debt financing. The financing agreement also includes the option to secure a further $5,000,000 in equity which would bring the total value of the financing agreement to $13 million in equity investment. Fox Petroleum currently has no debt obligations and no debt financing.

Capital Expenditures for Exploration

To date, Fox has received $2,000,000 ($2 Million) for the purpose of advancing exploration plans for the Company's various projects.

"We are very excited to have signed a financing agreement and to have raised this capital. The initial $2 Million received will allow us to advance our current projects significantly." said Alex Craven, Fox's VP Finance. "Now, in addition to continuing our already existing exploration activities, we can also expand as needed to fully exploit the oil and gas potential of our projects while knowing we have the capital available based on our needs for the long term growth of the company."

The securities offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent a registration or an applicable exemption from the registration requirements.

About Fox Petroleum

Fox Petroleum Inc. is an Oil and Gas Exploration company headquartered in London, England, the financial capital of Europe. Fox's Petroleum Inc has signed an agreement to acquire approximately 32,000 acres of prime land holdings in the North Slope of Alaska. The Company's shares are publicly traded on the NASD OTC BB under the ticker symbol FXPE.

GO TO http://www.foxpetro.com/ and sign up TODAY to get breaking news direct to your desktop as it becomes available.


On behalf of the Board of Directors
FOX PETROLEUM INC.

Alex Craven,
VP Finance
Forward-Looking Statements

Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management, including, but not limited to, the Company's belief that Fox Petroleum Inc. can identify and successfully negotiate leases for oil and gas properties, and that the Company can participate in the exploration of those properties. Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the US Securities and Exchange Commission.

Source: Fox Petroleum Inc.



----------------------------------------------
Fox Petroleum Inc.
Alex Craven
VP Finance
Investor Relations
Toll Free: 1-888-FOX-4744 (1-888-369-4744)
Email: [e-mail]
Website: www.foxpertro.com

[Rager]

Well this one is worth watching as stated...

"These acquisitions will provide a major growth opportunity for Graymark and a substantial increase in revenues"

[rlangmaid]

I know a John Simonelli!

[Rager]

GRMK...
one to watch, out of movies into Medical Industry
(.30 x .75)
Shares Outstanding: 8.74M
Float: 2.82M


Graymark Productions Signs Letter of Intent to Acquire Two Companies in the Medical Industry
May 24, 2007 12:32:00 PM
Copyright Business Wire 2007
OKLAHOMA CITY--(BUSINESS WIRE)--

Graymark Productions Inc. (OTCBB:GRMK), announced today that it has entered into a Letter of Intent to acquire Apothecary RX LLC., and Sleep Holdings, LLC. The acquisitions involve exchanging Graymark common stock for the ownership interests in the two companies. The acquisitions are contingent on further due diligence by Graymark and the signing of a definitive exchange agreement.

Apothecary RX LLC owns and operates eight independent pharmacies located in Missouri, Minnesota, and Oklahoma. Sleep Holdings LLC owns and operates seven state-of-the-art sleep centers that diagnose and treat a full range of sleep disorders ranging from insomnia to obstructive sleep apnea. The centers are located in Oklahoma and Texas. Controlling interests in both companies are held by Roy T. Oliver, one of Graymark's principal shareholders, and Stanton Nelson, a Director of Graymark.

Upon closing of the transactions, Graymark Productions will change its focus from motion picture production to the operation and management of medical-related companies. Graymark hopes to close the acquisitions within the next few months.

John Simonelli, Chairman and CEO of Graymark Productions Inc., stated, "We look forward to this change of direction for Graymark. These acquisitions will provide a major growth opportunity for Graymark and a substantial increase in revenues, which are anticipated to move the Company into profitability."

This press release may contain forward-looking statements which are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties which could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Source: Graymark Productions Inc.



----------------------------------------------
Graymark Productions Inc.
Oklahoma City
John Simonelli
405-601-5300

[Rager]

CTUM - CSMG Technologies Forms Five Subsidiaries Under Live Tissue Connect, Inc.
May 24, 2007 10:43:00 AM
Copyright Business Wire 2007
CORPUS CHRISTI, Texas--(BUSINESS WIRE)--

CSMG Technologies, Inc., (OTC Bulletin Board: CTUM) a technology management company, announced today it has formed five medical procedure specific subsidiaries wholly owned by its Live Tissue Connect, Inc. subsidiary .

The subsidiaries are being established for: Gynecology and General Surgery (GSG Medical Group), Orthopedics & Arthroscopy (Orthopedic Tissue Sciences), Colon Rectal Surgeries (Colorectal Connection Management), Pulmonary/lung (Pulmonary Sealing Sciences) and Urology (Urological Tissue Welding).

Donald S. Robbins, president and CEO of CSMG, said, "For some time we have been working toward isolating procedures and products for specific medical specializations. Now that we are completing final development of commercial instruments, design and electro surgery generator. With FDA filings immanent we are attracting interest from many qualified medical device companies and distributors who want to represent, license or market some area of the LTC product. We have thus far identified 12 specific procedure divisions but will establish the first five that are closest to product and market completion. Each of the LTC wholly owned subsidiaries represents a unique manufacturing, marketing or licensing opportunity under the LTC banner. This is truly a major commercial milestone for our company and I believe this approach adds considerable value to the company."

LTC's Frank D'Amelio added, "With a divisional, subsidiary structure we can leverage LTC's R&D developments across multiple medical disciplines. For example, the R&D effort that went into the development of a sealing device for gynecological arteries and veins can be leveraged into a similar acting device (though most likely different in shape/size) for Urological procedures. This structure allows potential partners to select surgical specialties where they have strong physician relationships and pre-existing distribution channels and discuss with LTC sales/marketing of LTC's unique bipolar products within such specialties."

CSMG owns the technology and exclusive world rights to the live tissue bonding device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology.

LTC expects to complete hand instruments, electrocautery generator and other electrosurgery components for the duct and vessel sealing system, meeting FDA and European CE Mark requirements, respectively. They also expect to start filing for approval of these devices with regulatory entities in early 2007.

About CSMG Technologies' Tissue Welding/Bonding Technology

The LTC tissue bonding / welding device is a platform technology that bonds and reconnects living soft biological tissue through fusion without the use of foreign matter in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues.

Surgeons at 27 Ukraine hospitals and clinics are using the tissue welding/bonding technology in clinical trials. They have completed more than 7,000 human surgeries using more than 80 types of open and laparoscopic surgical procedures, demonstrating the technology is universal in its ability to repair soft biological tissue. These surgeries included lung, neuro-surgery, nasal septum, intestine, stomach, skin, gall bladder, liver, spleen, blood vessels, nerves, alba linea, uterus, bladder, gynecological, fallopian tube, ovary and testicles and dura-matter. Cosmetic surgeries conducted with this technology include breast reduction, breast implants, mastopexy and abdominoplasty. The procedure involves little or no scarring, while restoring the normal function of the body organ or tissue.

The technology was invented and developed at the internationally renowned E.O. Paton Institute of Electric Welding, National Academy of Sciences of Ukraine, Kiev, Ukraine, headed by Professor B.E. Paton. U.S., Australian, Canadian and European Union patents have been issued, and additional U.S. and foreign patents are pending, all owned by LTC.

About CSMG Technologies, Inc.

CSMG Technologies is a technology management company that finances, owns, develops, licenses and markets innovative advanced technologies and business opportunities created in the Ukraine through a network of scientific institutes and private organizations. CSMG is focused on two primary subsidiaries, Live Tissue Connect, Inc. and landfill gas processing.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.ctum.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to http://www.ctum.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

Source: CSMG Technologies, Inc.



----------------------------------------------
CSMG Technologies
Inc.
Donald S. Robbins
President and CEO
361-887-7546
or
K. Bruce Jones
770-955-0409
or
ROI Group Associates
Inc.
Michael Dodge
212-495-0744
[e-mail]
or
Bob Giordano
212-495-0201

[Rager]

SHDG - Agreement for Biochemical Defense System
May 24, 2007 9:15:00 AM
CARY, NC -- (MARKET WIRE) -- 05/24/07 -- Shine Holdings, Inc. (PINKSHEETS: SHDG) announces it has executed a formal letter of intent to enter into an agreement to license its Biochemical Defense System(TM) to U.S. BioDefense, Inc., a Department of Defense Central Contractor developing homeland security and leading-edge biotechnologies.

Under the agreement, U.S. BioDefense expects to secure an exclusive licensing agreement from Shine Holdings for an annual fee of $100,000. The technology focuses on safeguarding domestic water supplies from potential bioweapons agents such as anthrax, botulism, tularemia, and viral hemorrhagic fevers (VHFs).

Full terms of the agreement are currently not disclosed as both firms will evaluate the technology and its potential on an ongoing basis in both laboratory analysis and the marketplace.

"We are confident that this development heralds significant potential. We look forward to working together with U.S. BioDefense to help them tap into a $400 billion industry," said Brett Swailes, CEO of Shine Holdings.

About Shine Holdings, Inc.

Headquartered in Cary, North Carolina, Shine Holdings has a core focus of creating patented technologies for sale and licensing so as to provide shareholders with capital appreciation and income. Its global mission is to create a legacy in water processing by efficiently restoring clean, pure water for drinking, agriculture, and aquaculture. Company website at: http://www.shine-holdings.com/index.htm

About U.S. BioDefense, Inc.

U.S. BioDefense is a Department of Defense Central Contractor that researches, develops, and commercializes homeland security and leading-edge biotechnologies. U.S. BioDefense is focused on transferring, researching, and commercializing groundbreaking technologies from Universities, Research Labs, Fortune 500 Companies, and Government Agencies. Through its subsidiary Emergency Disaster Systems (EDS), the company operates its Emergency Preparedness Program as part of its Homeland Security division. U.S. BioDefense is focused on developing EDS as an industry leader in the disaster mitigation and preparedness arena, an underserved market that could see consumer spending of over 24 billion dollars in 2007.

Forward-Looking Statements

This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance. Such statements are subject to risks and uncertainties and other factors as may be discussed from time to time in the Company's public filings with the U.S. Securities and Exchange Commission ("Commission"), press releases and verbal statements that may be made by our officers, directors or employees acting on our behalf which could cause actual results to differ materially from those discussed in the forward-looking statements and from historical results of operations. In addition to statements, which explicitly describe such risks and uncertainties, statements with the terms "believes," "belief," "expects," "plans," "anticipates" and similar statements should be considered uncertain and forward looking. Factors that might cause such a difference include, without limitation: the uncertainty of the Company's ability to meet capital needs and as further set forth in our public filings filed with the Commission and our press releases.

Contact:
Shine Holdings, Inc.
Investor Relations
919-654-3014

[Rager]

TZMT - Telzuit Medical Technologies: Director Provides Loan to the Company to Build Inventory
May 24, 2007 8:55:00 AM
ORLANDO, FL -- (MARKET WIRE) -- 05/24/07 -- Michael Vosch, an officer and director of Telzuit (OTCBB: TZMT), has loaned the Company approximately $220,000 so that Telzuit can build adequate product inventory. Mr. Vosch sold 3 million shares of stock in a private transaction and loaned the net proceeds to the Company.

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http//:www.telzuit.com

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact:

Jerry Balter
Chief Financial Officer
Telzuit Medical Technologies, Inc
407-354-1222

[Rager]

MITI - Micromet and Nycomed Enter Into Exclusive Worldwide Collaboration to Develop and Commercialize Anti-GM-CSF Antibodies for the Treatment of Inflammatory and Autoimmune Diseases
May 24, 2007 8:04:00 AM
BETHESDA, Md., and ROSKILDE, Denmark, May 24 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) and Nycomed today announced an agreement under which the two companies will collaborate on the development of anti-GM-CSF antibodies that may be useful for the treatment of inflammatory and autoimmune diseases. The lead product candidate in the collaboration is Micromet's MT203, a human antibody which neutralizes granulocyte macrophage colony-stimulating factor (GM-CSF), a cytokine known to play a significant role in autoimmune and inflammatory disease. Preclinical studies performed by Micromet support the development and evaluation of MT203 for the treatment of rheumatoid arthritis, multiple sclerosis, psoriasis, asthma and chronic obstructive pulmonary disease. MT203 is expected to enter clinical trials in 2008.

Under the terms of the agreement, Micromet will receive an upfront license fee of euro 5 million (approximately $7 million), and is eligible to receive R&D reimbursements and payments upon the achievement of development milestones of more than euro 120 million (approximately $160 million) in the aggregate. In addition, Micromet is eligible for royalties on worldwide sales of MT203 and other products that may be developed under the agreement. Micromet will be primarily responsible for performing preclinical development, process development and manufacturing of MT203 for early clinical trials, whereas Nycomed will be responsible for clinical development and commercialization on a worldwide basis. Nycomed will bear the cost of development activities and reimburse Micromet for its expenses incurred in connection with the development program.

"We are delighted to enter into a collaboration for the development of MT203 with our new partner Nycomed. We are excited about this collaboration as both parties' expertise and capabilities complement each other," said Christian Itin, President and Chief Executive Officer of Micromet.

"Neutralizing GM-CSF presents a new biology concept in inflammatory processes and may have the potential to improve the lives of patients suffering from severe chronic inflammatory and autoimmune diseases. Furthermore, this deal is the first example of Nycomed's strong commitment towards external collaborations across all development stages as a key component of our new R&D strategy. MT203 also highlights our strategic interest in inflammatory research," said Anders Ullman, Executive Vice President R&D of Nycomed.

About Nycomed (http://www.nycomed.com)

Nycomed is a pharmaceutical group which provides products for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. The company is active within a range of therapeutic areas, including cardiology, gastroenterology, Osteoporosis, respiratory, pain and tissue management. New products are sourced both from own research and from external partners. Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide. Privately owned, the combined group had non-audited estimated annual sales of approximately euro 3.4 billion and an EBITDA of euro 933.4 million (2006 results).

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. MT103/MEDI-538, which is the first product candidate based on Micromet's novel BiTE(R) product development platform, is being evaluated in a phase 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, widely recognized as the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant human monoclonal antibody which targets EpCAM expressing tumors, has completed two phase 2a clinical trials, one in patients with breast cancer and the other in patients with prostate cancer. In addition, a phase 1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Micromet has established collaborations with MedImmune, Inc. for MT103/MEDI-538 and Merck Serono for adecatumumab (MT201).

Forward-Looking Statements

For Micromet:

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding the intended utilization of product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research, discovery of new product candidates, and clinical trials, and partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risks associated with regulatory processes, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for future revenues under the terms of its existing collaboration agreements, and for further pre-clinical and clinical studies, development and commercialization of product candidates. You are urged to consider statements that include the words "appear," "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed in Micromet's periodic reports and other filings with the SEC, including the "Risk Factors" sections of such reports.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Micromet, Inc.



----------------------------------------------
Chris Schnittker
SVP & CFO
[phone]
[e-mail]
or Investors
Susan Noonan
[phone]
[e-mail]
or Media
Pat Garrison
[phone]
[e-mail]
all of Micromet
Inc.; or Christoffer Jensen
VP Communications of Nycomed
[phone]
or cell
[phone]

[Rager]

UTZE - PhoneBrasil Inc. Announces near Completion of Reverse Merger with UTZ Technologies, Inc.
May 23, 2007 10:06:00 AM
Copyright Business Wire 2007
CORAL SPRINGS, Fla.--(BUSINESS WIRE)--

UTZ Technologies, Inc. (Pink Sheets:UTZE) updates the investing community. PhoneBrasil, Inc. today confirmed the near completion of a reverse merger with publicly traded UTZ Technologies, Inc., and further announced that the merged entity would soon operate under the name PhoneBrasil International Inc.

President of UTZ Technologies Dennis Curtis stated, "In furtherance of the agreement between UTZE and PhoneBrasil, we have already filed and will soon be announcing the amended certificate to finalize the name change, symbol and cusip. The new cusip number for PhoneBrasil International Inc. is 71921A104. I would also like to welcome PhoneBrasil's upper management team and the fact that they will be coming on board after the reverse merger is completed. The management team includes President and CEO of PhoneBrasil Inc., Anderson Alves Dias, CFO Luis Cesar Busch Ziliotto, and Director Patricia Maris Mendes."

A UTZE company representative commented, "As a result of the reverse merger Dennis Curtis will continue as a director and advisor to the new company `PhoneBrasil International Inc.' and Anderson Alves Dias will become the new President and CEO."

CEO Anderson Alves Dias of PhoneBrasil commented, "I look to rapidly build shareholder value through strategic plans that have been put into place for the new PhoneBrasil International Inc."

PhoneBrasil is an American based company specializing in Hybrid VOIP Technology for the International market.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as UTZE or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Source: UTZ Technologies, Inc.



----------------------------------------------
UTZ Technologies
Inc.
Coral Springs
Dennis Curtis
President
754-366-2171
[e-mail]

[Rager]

EWIN - eWorld Interactive, Inc.: Proctor and Gamble Sees Next Top Branding Opportunity in "China's Next Top Model"
May 23, 2007 9:21:00 AM
SHANGHAI, CHINA -- (MARKET WIRE) -- 05/23/07 -- MOJO Media Works, a subsidiary of eWorld Interactive (OTCBB: EWIN), is pleased to announce that Proctor and Gamble ("P&G") has signed on as Title sponsor for "China's Next Top Model" in a deal worth RMB 8.5 million (over US$1 million). P&G's Pantene brand will enjoy top placement in the production's China debut next month.

P&G also has the right of first refusal to place additional brands in multiple other advertising slots built into the show's revenue model. P&G global brands include Cover Girl and Olay, which have made successful pushes into the Chinese market.

"China's Next Top Model" enters the growing Chinese media market as a result of a production and distribution agreement between MOJO and CBSParamount. MOJO's parent company, eWorld Interactive, also holds exclusive rights for related online content and interactive applications in Mainland China.

The sponsorship deal is a perfect match for top global brands P&G and "Next Top Model".

According to a FORTUNE article (Dec 12, 2005), P&G has long held the China leadership position in the broadly defined cosmetics and toiletries industry, partly because its shampoos (Rejoice, Head & Shoulders, and Pantene) hold the top three hair-care positions in the market. P&G hauls in more than $2 billion in annual sales in China - roughly 70% of that from hair and skin products.

As for the "Next Top Model" phenomena, the original series "America's Next Top Model", created by supermodel Tyra Banks and now in its 9th cycle, ranks #1 in international television series sales. MOJO is the exclusive producer and distributor for the localized version "China's Next Top Model."

"We couldn't ask for a better sponsor for the China's Next Top Model production," said MOJO Managing Director Kin Mak. "It is especially exciting as the P&G deal covers not only traditional broadcast but also ancillary placements reaching into the online world via our www.17dian.cn portal. Major sponsors are really getting behind the new ad models emerging in China."

MOJO's technical strength brings additional advertising opportunities.

As a division of eWorld Interactive (OTCBB: EWIN), MOJO is utilizing the parent company's strength in technology development to create innovative media features that are attractive to major advertisers like P&G. For example, China's Next Top Model will feature weekly online talk shows, a webcast, an interactive fan site, online product placement and unique merchandising opportunities.

ON BEHALF OF THE BOARD

Guy Peckham, CEO, eWorld Interactive, Inc.

About eWorld:

eWorld Interactive is a second-generation media and entertainment portal in Mainland China and other Asian markets. The company has assembled a portfolio of multi-media content and applications that provide advertising access to a large customer base in the region. eWorld is a compelling place for individuals to interact with top media franchises as well as create and share their videos, photos, music, and online experiences. Offline products and video production capabilities allow the company to create higher value offerings to content providers and sponsors.

This press release contains forward-looking statements which are statements that are not historical facts and are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in such. Although we believe the expectations reflected in our statements are reasonable, results may vary, and we cannot guarantee future results, levels of activity, performance or achievements. This news release has been prepared by management of the Company who takes full responsibility for its contents. No regulatory authorities either reviewed or approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Contacts:
eWorld Interactive, Inc.
Guy Peckham
CEO
[phone]
Website: www.eworldchina.cn

[Rager]

SIGN up 42% last 2.50 ask 3.00

[Rager]

fyi NVEA...

... 4 for 1 F/S...

(was VEND, Current Capital Change:
shs decreased by 1 for 100 split
Pay Date: 2007-04-03 )
(Level 2 is wild)


NVEA -- Nouveau International, Inc.
Com ($0.001)(New)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

Nouveau International Inc. to Change Name to My Screen Mobile Inc.

TORONTO, Apr 13, 2007 (PrimeNewswire via COMTEX) -- Nouveau International Inc. (Pink Sheets:NVEA) will change its corporate name to My Screen Mobile, Inc. to further reflect the new focus of the corporation's activities going forward. In addition the company will be filing a 4 for 1 forward split of the company's common shares.
This press release contains "forward looking" statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward-looking statements as a result of risk factors discussed in Nouveau International, Inc. reports that will be on file with the U.S. Securities and Exchange Commission.

This news release was distributed by PrimeNewswire, www.primenewswire.com

SOURCE: Nouveau International, Inc.


By Staff

CONTACT: Nouveau International Inc.
Terrence Rodrigues
647-885-6470


(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.

-0-

SUBJECT CODE: STOCK NEWS
Restructuring Recapitalization
Stock Market News

[Rager]

SPAN - Span-America Key Dates for $5.00 Per Share Special Cash Dividend
RECORD DATE MAY 23, 2007 PAYMENT DATE JUNE 6, 2007 EX-DIVIDEND DATE JUNE 7, 2007
May 22, 2007 1:20:00 PM
Copyright Business Wire 2007
GREENVILLE, S.C.--(BUSINESS WIRE)--

Span-America Medical Systems, Inc. (NASDAQ: SPAN) has declared a special, one-time cash dividend of $5.00 per share to shareholders of record on May 23, 2007. The payment date for the dividend is June 6, 2007. The special dividend is in addition to the regular quarterly dividend of $0.08 per share, which has the same record and payment dates.

Span-America's common stock will begin trading on an ex-dividend basis for the $5.00 per share special dividend on June 7, 2007, the day after the payment date, in accordance with NASDAQ listing rules. Shareholders who sell their shares on or before the payment date of June 6, 2007, will also be selling their right to receive the special dividend. Shareholders are advised to contact their financial advisor before selling their shares.

About Span-America Medical Systems, Inc.

Span-America manufactures and markets a comprehensive selection of pressure management products for the medical market, including Geo-Matt(R), PressureGuard(R), Geo-Mattress(R), Span+Aids(R), Isch-Dish(R), and Selan(R) products. The Company also supplies custom foam and packaging products to the consumer and industrial markets. Span-America's stock is traded on The NASDAQ Global Market under the symbol "SPAN." For more information, visit www.spanamerica.com.

Source: Span-America Medical Systems, Inc.



----------------------------------------------
Span-America Medical Systems
Inc.
Jim Ferguson
864-288-8877 ext. 6912

[Rager]

ECSI...
We approved amendment our Articles of Incorporation to effect a 3-for-1 forward stock split of our issued and outstanding Common Stock
Shareholders of record at the close of business on May 28, 2007, the Record Date, are entitled to notice of the action to be effective on or about June 5, 2007

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY

The actions to be effective twenty days after the mailing of this Information Statement are as follows:

(1) We approved amendment our Articles of Incorporation to change our name to Clarity MD, Inc.; and



(2) Three members were elected to the Company's Board of Directors to hold office until the Company's Annual Meeting of Stockholders in 2008 or until his successor is duly elected and qualified; and



(3) The appointment of Meyler & Company LLC as the Company's independent certified public accountants was ratified; and



(4) The Company’s 2007 Stock Option Plan was ratified; and



(5) We approved amendment our Articles of Incorporation to effect a 3-for-1 forward stock split of our issued and outstanding Common Stock



(6) We approved amendment our Articles of Incorporation to include a Preferred Stock, $0.001 par value per share with such rights and preferences as designated by the Board of Directors.

[Rager]

yep

[cintrix]

Those are all going pink tomorrow, Jeff?

[Rager]

SECURITY ADDITIONS ...
from OTCBB to pinks
(yowza)

Updated Symbol Company Name Effective Date/Comments
13:51 ADMH Admiralty Holding Company Common Stock 5/22/2007 From BB (ADMHE)**
13:51 AEXG Amerex Group, Inc. Common Stock 5/22/2007 From BB (AEXGE)**
13:51 ASPR Adsouth Partners, Inc. Common Stock 5/22/2007 From BB (ASPRE)**
13:51 AVTO Avantogen Oncology, Inc. Common Stock 5/22/2007 From BB (AVTOE)**
13:51 BNRJF Benton Res Corp Common Shares (Canada) 5/22/2007
13:51 CANM Caneum, Inc. Common Stock 5/22/2007 From BB (CANME)**
13:51 CHMS China Mobility Solutions, Inc. Common Stock 5/22/2007 From BB (CHMSE)**
13:51 CIGI Coach Industries Group, Inc. Common Stock 5/22/2007 From BB (CIGIE)**
13:51 CRVU CorVu Corporation Common Stock 5/22/2007 From BB (CRVU)**
13:51 CTHH Catcher Holdings, Inc. Common Stock 5/22/2007 From BB (CTHHE)**
13:51 DDSU DDS Technologies USA, Inc. Common Stock 5/22/2007 From BB (DDSUE)**
13:51 ELCO Elcom International, Inc. Common Stock 5/22/2007 From BB (ELCOE)**
13:51 EMFP EMERGENCY FILTRATION PRODUCTS Common Stock 5/22/2007 From BB (EMFPE)**
13:51 ESHEQ EarthShell Corporation Common Stock 5/22/2007 From BB (ESHQE)**
13:51 FOFH Forefront Holdings, Inc. Common Stock 5/22/2007 From BB (FOFHE)**
13:51 GAMT Global Entertainment Holdings/Equities, Inc. Common Stock 5/22/2007 From BB (GAMTE)**
13:51 GBMR Global Matrechs, Inc. Common Stock 5/22/2007 From BB (GBMRE)**
13:51 GENG Global Energy Group, Inc. Common Stock 5/22/2007 From BB (GENGE)**
13:51 GLMA Glassmaster Company Common Stock 5/22/2007 From BB (GLMAE)**
13:51 GPMIJ Gray Publishing and Media Inc Del Common shares 5/22/2007
13:51 GRPK Gray Peaks, Inc. Common Stock 5/22/2007 From BB (GRPKE)**
13:51 GRWW Greens Worldwide Incorporated Common Stock 5/22/2007 From BB (GRWWE)**
13:51 HESG Health Sciences Group, Inc. Common Stock 5/22/2007 From BB (HESGE)**
13:51 HLEG Headliners Entertainment Group, Inc. Common Stock 5/22/2007 From BB (HLEGE)**
13:51 IACH Information Architects Corporation Common Stock 5/22/2007 From BB (IACHE)**
13:51 ISMN IFSA Strongman, Inc. Common Stock 5/22/2007 From BB (ISMNE)**
13:51 ITOU In Touch Media Group, Inc. Common Stock 5/22/2007 From BB (ITOUE)**
13:51 ITYS International Technology Systems, Inc. Common Stock 5/22/2007 From BB (ITYSE)**
13:51 IVPC Inverted Paradigms Corporation Common Stock 5/22/2007 From BB (IVPCE)**
13:51 LOGE Long-e International, Inc. Common Stock 5/22/2007 From BB (LOGEE)**
13:51 MHLX microHelix, Inc. Common Stock 5/22/2007 From BB (MHLXE)**
13:51 MIGA Migami, Inc. Common Stock 5/22/2007 From BB (MIGAE)**
13:51 MOAT Castleguard Energy, Inc. Common Stock 5/22/2007 From BB (MOATE)**
13:51 MRDG Miracor Diagnostics, Inc. Common Stock 5/22/2007 From BB (MRDGE)**
13:51 OIVO One IP Voice, Inc. Common Stock 5/22/2007 From BB (OIVOE)**
13:51 OTCI Ortec International, Inc. Common Stock 5/22/2007 From BB (OTCIE)**
13:51 PDIV Premier Development & Investment, Inc. Class A Common Stock 5/22/2007 From BB (PDIVE)**
13:51 PDVG Pride Business Development Holdings, Inc. Common Stock 5/22/2007 From BB (PDVGE)**
13:51 PNOT Path 1 Network Technologies, Inc. New Common Stock 5/22/2007 From BB (PNOTE)**
13:51 RAFI Regency Affiliates Inc Common Stock 5/22/2007 From BB (RAFIE)**
13:51 RPDAF RP Data Ltd Ordinary Shares (Australia) 5/22/2007
13:51 SFIN Safetek International, Inc. Common Stock 5/22/2007 From BB (SFINE)**
13:51 SNSAY Stolt-Nielsen S.A. American Depositary Shares 5/22/2007 From Q (SNSA)
13:51 SRGL SurgiLight, Inc. Common Stock 5/22/2007 From BB (SRGLE)**
13:51 SYUP Shanghai Yutong Pharma, Inc. Common Stock 5/22/2007 From BB (SYUPE)**
13:51 TCLL Tricell, Inc. Common Stock 5/22/2007 From BB (TCLLE)**
13:51 TLYH Tally-Ho Ventures, Inc. Common Stock 5/22/2007 From BB (TLYHE)**
13:51 TOFS 247MGI, Inc. Common Stock 5/22/2007 From BB (TOFSE)**
13:51 TRINQ Trinsic, Inc. Common Stock 5/22/2007 From BB (TRIQE)**
13:51 TRYT Trinity3 Corporation Common Stock 5/22/2007 From BB (TRYTE)**
13:51 TSIX 360 Global Wine Company Common Stock 5/22/2007 From BB (TSIXE)**
13:51 VLDI Validian Corporation Common Stock 5/22/2007 From BB (VLDIE)**
13:51 WGLT WGL Entertainment Holdings, Inc. Common Stock 5/22/2007 From BB (WGLTE)**
13:51 WLKF Walker Financial Corporation Common Stock 5/22/2007 From BB (WLKFE)**
13:51 ZERO Save The World Air, Inc. Common Stock 5/22/2007 From BB (ZEROE)**

[Rager]

CYRR - Canary Resources and K C Clean Energy LLC Form Drilling Program for CBM Gas
Canary Resources Inc. (PINKSHEETS: CYRR) ("Canary") today announced that its wholly owned subsidiary Canary Operating Corporation has entered into an agreement for a joint venture Drilling Program with K C Clean Energy LLC which will participate on a turnkey cost basis. The first phase of the Drilling Program involves a commitment for 20 wells. Canary is to drill 16 new wells in which K C Clean Energy LLC will acquire a 50% working interest, and K C Clean Energy LLC will purchase a 50% working interest in 4 of Canary's existing wells. Canary will operate all 20 wells, and will retain a 50% working interest in them. Upon completion of the first phase of the Drilling Program, K C Clean Energy LLC has the right to participate in an additional phase for up to 20 more wells.

"Our agreement with K C Clean Energy enables Canary to speed up drilling and development of coal-bed methane gas in the Eastern Forest City Basin of Kansas and Missouri," explained William Chandler, Chief Executive Officer of Canary. "Our equipment and crews are on location, wells are permitted and Canary is starting to drill immediately," he said.

Canary recently completed construction of its wholly owned tap into the Southern Star Central Gas Pipeline in Kansas, and is finalizing the engineering and regulatory testing for the interconnect facility. Canary has 19 completed gas wells, presently shut-in pending pipeline connection, with 12 wells adjacent to its Southern Star interconnect. The 16 new wells to be drilled under the joint venture Drilling Program will also be located near the interconnect. Initial indications from the wells near the tap are positive: all have good gas shows and are expected to be productive wells. Hook-up of the wells is underway, and Canary expects to achieve commercial gas production, and start realizing transportation fees in the second quarter of 2007.

Canary Resources Inc. is independent Oil and Natural Gas Company engaged in the acquisition, exploitation, production and development of oil and natural gas properties in Johnson and Miami Counties, Kansas, and in Bates and Cass Counties, Missouri, for which it is the operator. Canary has offices in Houston, Texas, and Stilwell, Kansas.

Additional information on Canary Resources Inc. is available from: [e-mail].

Or visit the Company's website at http://www.CanaryResources.com

Portions of this document include "forward-looking statements," which may be understood as any statement other than a statement of historical fact. Forward-looking statements contained in this document are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "potential" and similar expressions. Actual results may vary materially from management's expectations and projections expressed in this document. Certain factors that can affect the Company's ability to achieve projected results include, among others, production variances from expectations, uncertainties about estimates of reserves, volatility of oil and gas prices, the need to develop and replace reserves, the substantial capital expenditures required to fund operations, environmental risks, drilling and operating risks, risks related to exploratory and development drilling, competition, government regulation and the ability of the Company to implement its business strategy.

Copyright 2007. All rights reserved Canary Resources Inc.

Image Available: http://www.marketwire.com/mw/frame_mw?attachid=495732


Additional information on Canary Resources Inc. is available from:
[e-mail]
Or visit the Company's website at http://www.CanaryResources.com





Source: Market Wire (May 21, 2007 - 9:35 AM EDT)

News by QuoteMedia
www.quotemedia.com

[Rager]

EESX, trading pre bell..2.70 x 2.75

[Rager]

BKYI - BIO-key Announces Sale of Fire Safety Division to NYSE Listed Company
New Liquidity Enables Greater Focus And Investment In Core Law Enforcement and Biometrics Business
May 21, 2007 7:30:00 AM
WALL, N.J., May 21 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, today announced that it has reached an agreement, subject to customary closing conditions, to sell its Fire Safety business for $7 million in cash. Proceeds from the transaction will be applied to repaying debt and will be used for working capital to expand the company's core Law Enforcement and Biometrics business. The purchaser is a world leader in public safety software solutions and is a division of a publicly traded New York Stock Exchange Company. The acquirer will be making a separate announcement on this purchase.

"The sale of our Fire Safety Division enables BIO-key to focus its resources on the Company's core business; developing unique applications for mobile and handheld devices used by law enforcement and public safety professionals and advanced biometric identification solutions," said Michael DePasquale, BIO-key's Chief Executive Officer. "We paid approximately $2 million dollars for the Fire Business in 2004 as part of the acquisition of the Mobile Government Division from Aether Systems. As a result of our investments in technology and customer service, we are proud of the value we created for our shareholders in the three years since we purchased this business. The sale of this non-strategic business will allow us to eliminate all our senior secured debt and provide the working capital to accelerate our efforts to develop new software that melds the best of our biometric and law enforcement businesses. With improved liquidity and a stronger balance sheet, we believe we are now also better positioned for strategic growth opportunities."

BIO-key plans on applying a portion of the sale proceeds to fully repaying its $4.3 million in convertible debt obligations. Additional detail on the transaction will be provided on BIO-key's first quarter 2007 earnings conference call as detailed below.

Conference Call Details

BIO-key has scheduled a call for Monday, May 21st at 9:00 a.m. Eastern Time to discuss first quarter 2007 financial results. Dialing 303-262-2125 and asking for the BIO-key call at least 10 minutes prior to the start time can access the conference call live. The conference call will also be broadcast live over the Internet by logging onto http://www.bio-key.com. A telephonic replay of the conference call will be available through May 29th, 2007 and may be accessed by dialing 303-590-3000 and using the pass code 11089929#. Additionally, an archive of the webcast will be available shortly after completion of the call on the Company's website (http://www.bio-key.com) for a period of three months.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 2,500 police, fire and emergency services departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for public safety worldwide. (http://www.bio-key.com)

This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. The words "estimate," "project," "intends," "expects," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Media Contact: BIO-key International, Inc.
Bud Yanak
732-359-1113

Investor Contact: DRG&E
Gus Okwu, Managing Director
404-892-8178
SOURCE BIO-key International, Inc.



----------------------------------------------
Bud Yanak of BIO-key International
Inc.
[phone]; or Gus Okwu
Managing Director of DRG&E
[phone]
for BIO-key International
Inc.

[Rager]

cheese burger

HMIT
Hidalgo Mining International Embarks On The Multi-Billion Dollar Coal Mining Industry as It Begins Trading Under Symbol (HMIT). Geographical and Engineering Studies Confirm Three High-Grade Coal Seams on Site.
May 21, 2007 7:29:00 AM
Copyright Business Wire 2007
NEW YORK--(BUSINESS WIRE)--

Hidalgo Mining International (PINK SHEETS: HMIT), an innovative coal mining company headquartered in New York with coal properties located in Northern Mexico, announced today that it has initiated trading under the symbol: (HMIT).

Hidalgo Mining embarks on the multi-billion dollar coal mining industry as it encompasses nearly 50,000 acres of coal properties located approximately 5 miles south of the border of Texas in Northern Mexico. The described property was targeted for initial operation as a result of its heightened quality of coal and its relative proximity to both the Mexican rail lines and power plants in Northern Mexico, where HMIT will target a large majority of its production sales. Utilizing such a property will reduce the conventional costs of delivering coal as it inherits logistical simplicity through its geographical location.

HMIT COAL PROPERTY STUDY

Extensive geological and engineering studies have been completed confirming three coal seams averaging 0.5-1.2 meters in thickness underneath 10 - 12 meters of overburden (the earth that covers the coal seam). The evaluation was completed in October of 2004 including over 400 rotary and cord drilled holes, with test mining concluded in 2006. Studies have additionally concluded that the coal assets located on site are of "high-grade" nature commonly labeled as Bituminous Coal, which is foreseen by the industry as a less common and more demanded level of coal.

HMIT intends to initiate "Phase 1" of its mining project upon the completion of funding that is anticipated to close during the later part of the present week. Funding would initiate the first phase of mining which would result in drastic revenue reception for the company as well as the initiation of a global marketing campaign to vend off the acquired coal assets.

ABOUT COAL MINING

Coal was one of man's earliest sources of heat and light. The Chinese were known to have dug it more than 3,000 years ago. The first recorded discovery of coal in this country was by French explorers on the Illinois River in 1679, with the earliest recorded commercial mining in the U.S. occurring near Richmond, Virginia, in 1750. In the nineteenth century, coal grew rapidly in demand as it became our most desired energy fuel source from 1850 to 1950.

Today, coal is the driver of a multi-billion dollar a year industry, accounting for over half of our electric power generation, supplying coke for the steel industry, and providing a source of foreign exchange as an export commodity.

At the time of writing, coal is utilized to generate almost all of Mexico's electric power. Forecasters predict an even more robust role for coal in the future as electric power continues to grow as one of the world's leading sources of energy. More importantly, work on new coal combustion technologies is advancing in response to society's demands that a clean environment be maintained and researchers within the industry, universities, and the government are continuing their efforts to develop new ways for this ancient gift to continue serving modern society.

Learn more about Hidalgo Mining International by visiting:

www.hidalgointernational.com

Disclaimer:

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. These expectations and assumptions are subject to risks and uncertainty, which could affect Hidalgo Mining Internationals' future plans. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of Hidalgo Mining International to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks detailed in Hidalgo Mining Internationals' periodic report filings with the Securities and Exchange Commission. Hidalgo Mining International undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in Hidalgo Mining Internationals' expectations.

Source: Hidalgo Mining International



----------------------------------------------
Investor Relations for Hidalgo Mining International
Veronica D. Dunford
310-729-1223
[e-mail]

[Rager]

burger...
XKEM - Xechem Achieves Another Milestone: Receives Approval of US $9.38 Million Funding by UPS Capital and the U.S. EX-IM Bank
Monday May 21, 6:30 am ET


NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Xechem International, Inc. (OTC BB: XKEM - News) announced today that the UPS Capital Business Credit and the United States Export Import (EX-IM) Bank has received all the required approvals in connection with a US $9.38 million EX-IM loan guarantee for Xechem Pharmaceuticals Nigeria, Ltd. (Xechem Nigeria). The UPS Bank has now approved the funding of the loan in accordance with the guidelines and requirements of the EX-IM Bank loan guarantee program.



In October 2006, EX-IM Bank, the official credit export agency of the United States, had approved a Comprehensive Credit Guarantee to support the loan, subject to the condition that Xechem Nigeria obtains supporting guarantees from two suitable local banks. Diamond Bank Plc and Platinum Habib Bank Plc, both headquartered in Nigeria, have issued the required guarantees, paving the way for finalization and funding of the UPS loan. Personal guarantees were also provided to these banks by Dr. Ramesh C. Pandey, Chairman & CEO of Xechem International, Inc. and Xechem Pharmaceutical Nigeria Ltd., and two Nigerian Board members, Dr. Adesoji Adelaja (also a Xechem International Board Member) and Mr. Isaac Inyang. The loan is for a five year term, bearing interest at LIBOR plus 2.75% and requires semi annual reductions of principal at 10% per period, together with payment of accrued, unpaid interest.

Funds Earmarked for Equipment, Corporate Offices and Manufacturing Facility

The funds provided by UPS Capital under the EX-IM guaranteed loan will be used to purchase the U.S. manufactured pre-fabricated corporate offices, warehouse, plant equipment and machinery needed by Xechem Nigeria to establish a state-of-the-art facility in the outskirts of Abuja, Nigeria, which is slated for completion during the fourth quarter of this year. The UPS loan is in addition to a separate loan of N350 Million Naira (approximately $2.7 million US Dollars) made in April 2007 to Xechem Nigeria by the Nigerian Export-Import (NEXIM) Bank for construction of manufacturing facility related costs, which supplements the N150 Million Naira (approximately US $1,157,000) of funds previously advanced by NEXIM. The expanded facility, once completed, will enable Xechem Nigeria to produce commercial scale quantities of NICOSAN(TM), Xechem's breakthrough medicine for the prophylactic management of Sickle Cell Disease (SCD).

"We are very pleased that all of the pieces to the approval and funding of this long awaited EX-IM guaranteed loan have finally come together," commented Dr. Ramesh C. Pandey, Chairman and CEO of Xechem Companies. "We can now turn our full attention to realizing our dream of completing the state-of-the-art laboratories and a cGMP production facility in Nigeria which will help us in the production of commercial scale quantities of NICOSAN(TM) to meet the needs of the millions of people afflicted with this terrible disease."

Dr. Pandey added, "We are very grateful to EX-IM Bank, UPS Business Credit, Diamond Bank and Bank PHB for their strong support for this important project and for helping us make the dream a reality. I am especially grateful to our consultants Financialbridge, Inc. and Mr. Isaac Inyang for their tireless efforts in seeing this through to a successful conclusion."

About NICOSAN(TM)

NICOSAN(TM) is an anti-sickling drug originally researched by the scientists at the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria. In clinical studies conducted under NIPRD's auspices, the drug showed substantial reduction in the degree of sickling of the red blood cells of those afflicted with the disease. While not a cure, the clinical trials have confirmed that the large majority of patients taking NICOSAN(TM) no longer experience sickle cell "crises" while on the medication, and even among those whose crises are not eliminated, the number and severity of the crises are substantially reduced. Through quality control/quality assurance (QC/QA) Xechem has standardized and verified the antisickling activity of the product, which is now called as NICOSAN(TM).

After the approval by the regulatory agency of Nigeria, National Agency for Food and Drug Administration and Control (NAFDAC), NICOSAN(TM) is being marketed in Nigeria since July 6th, 2006 on a limited basis. NICOSAN(TM) has Orphan Drug Designation in the US and EU countries.

About Xechem

Xechem International is a development stage biopharmaceutical company with expertise in developing drugs for Sickle Cell Disease (SCD), antidiabetic, antimalarial, antibacterial, antifungal, anticancer and antiviral (including AIDS) products from natural sources, including microbial and marine organisms. Its focus is on the development of proprietary technologies, including those used in the treatment of orphan diseases and phyto-pharmaceuticals (natural herbal drugs). Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN(TM) (to be marketed as HEMOXIN(TM) in the US and Europe). With the Nigerian regulatory approval now in hand, Xechem is now working on the commercialization of the drug in Nigeria and the pursuit of US FDA and European regulatory approval. In addition to NICOSAN(TM), Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University (VCU).

Forward Looking Statements

This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks and uncertainties. Such risks include the risk that: (i) there could be delays and/or cost overruns in connection with the build out of Xechem Nigeria's pilot plant facility to a full scale commercial production facility; (ii) there can be no assurances that Xechem Nigeria will be successful in its production or marketing of Niprsan (iii) the Company and/or Xechem Nigeria could suffer significant dilution from the raising of additional capital until such point in time as they achieve cash flow break even status, if at all; (iv) doing business in Nigeria is subject to all of the risks of operation in a foreign country and associated political and regulatory risks; and (v) operations of the Company could be disrupted due to the chronic limited availability of funds to meet ongoing obligations.



Contact:
Xechem
H. Scott English, 732-247-3302
Director, Investor Relations

--------------------------------------------------------------------------------
Source: Xechem International, Inc.

[Rager]

Forward looking...

DCBI

"We have groundbreaking news that we want to address with our shareholders in person and believe that those who attend will surely reap of the benefits of getting the news firsthand,"


The shareholder event will commence in the early afternoon on Saturday, July 28

DC Brands International, Inc.


DCBI.PK -DC Brands International Announces Shareholder Event Scheduled for July 28, 2007 in Las Vegas
Friday May 18, 8:40 pm ET


DENVER, CO--(MARKET WIRE)--May 18, 2007 -- DC Brands International (Other OTC:DCBI.PK - News) (DC Brands) is pleased to announce an exclusive shareholder meeting and reception is scheduled for July 28, 2007 in Las Vegas. The company is talking with three of Las Vegas' top venues to host the event, and exact details will be provided in formal invitations sent with the new issue of DC Brands' newsletter, which will ship in June.
DC Brands is currently trying to gauge shareholders' interest level, as the party may reach up to 2,000 attendees. Please email [e-mail] before May 31 if you are interested in attending and indicate the number of people in your party. The event is limited to current shareholders, and each shareholder can bring one guest.

ADVERTISEMENT


"We have groundbreaking news that we want to address with our shareholders in person and believe that those who attend will surely reap of the benefits of getting the news firsthand," said DC Brands President and CEO Richard Pearce. "New major accounts and even distribution to a new country are just two items on our agenda to discuss. By this time, we will have filed our 15-c-2-11 and will be a fully reporting company, opening an entirely new world. If the news we have is as good as we say, do the math."

As the shareholders know, two months ago the stock price went from $.03 to a high of $.37 based on the factual reporting of the success of the Turn Left launch and the repositioning of Dickens Energy Cider. This created a buying frenzy at a volume of more than 5 million shares a day, which brought unwanted attention from the SEC, shutting down trading temporarily. DC Brands immediately compiled a detailed due diligence file on each press release issued including the names, addresses, phone numbers and contacts for every person they met with. This file was made available to the SEC despite the fact that the SEC never requested it. The SEC was doing their job trying to protect the public from illegitimate companies and DC Brands, unfortunately, fit a profile of unprecedented growth and were found guilty without any notification.

Since that time, DC Brands has made a concerted effort to only issue basic maintenance releases without including any of the more compelling information until the company has the full bid/ask support completed. Thus DC Brands is holding all the more powerful news for the shareholder meeting to ensure all facets of the financial reporting are in line.

The shareholder event will commence in the early afternoon on Saturday, July 28, with a conference that will last approximately two hours. At this meeting Pearce, along with other company executives, distributors and partners, will highlight the exciting news along with information on DC Brands' financials and future outlook. That same evening, DC Brands will host a fully catered reception where shareholders can meet the company principals, new employees, sales reps and major retailers. DC Brands is also organizing discounted room blocks at several premier hotels.

For those who cannot attend, the meeting and reception will be videotaped and made available to all shareholders approximately four to six weeks later.

For more information on DC Brands International, visit their website at www.TurnLeftEnergy.com and DickensEnergyCider.com

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.



Contact:
CONTACT:
Aubrey Cornelius
303.495.2883











--------------------------------------------------------------------------------
Source: DC Brands International, Inc.

[Rager]

re: EESX
not trading yet, some info i found so far

The single consenting stockholder of Eastern Exploration is the record and beneficial owner of 10,000,000 shares, which represents approximately 70.55% of the issued and outstanding shares of Eastern Exploration’s common stock

Anthony Tai President, Chief Executive Officer, Secretary, Treasurer and Director

Authorized 75 ,000,000 shares of common stock, $0.001 par value,
Issued and outstanding 14,175,000 shares of common stock

Eastern Exploration Co.

Address:
6588 Barnard Drive
Suite 40
Richmond, BC V7C 5R8
CAN
Phone: [phone]

Current Capital Change:
shs increased by 4 for 1 split
Ex-Date: 2007-05-18
Record Date: 2007-05-17
Pay Date: 2007-05-17


Common stock issued for cash at $0.0004 per share
- October 21, 2005 10,000,000 1,000 3,000 - 4,000
Common stock issued for cash at $0.006 per share
- October 21, 2005 1,858,333 186 10,964 - 11,150
Common stock issued for cash at $0.006 per share
- December 2, 2005 1,075,000 107 6,343 6,450
Common stock issued for cash at $0.006 per share
- January 31, 2007 1,241,667 124 7,326 7,450

All share amounts have been restated to reflect the 5 to1 split in March 16, 2006. (Refer to note 4)


5/3/2007

NOTICE TO STOCKHOLDERS OF ACTION APPROVED BY CONSENTING STOCKHOLDERS

The following action was taken based upon the unanimous recommendation of Eastern Exploration’s Board of Directors and the written consent of the consenting stockholder:


APPROVAL TO AMEND CERTIFICATE OF INCORPORATION TO EFFECT A FORWARD STOCK
SPLIT AT A RATIO OF FOUR-FOR-ONE
AT ANY TIME AFTER MAY 24, 2007 AND BEFORE JUNE 15, 2007.


http://www.pinksheets.com/quote/print_filings.jsp?url=%2Fredirect.asp%3Ffilename%3D0001096906%252D07....

[Rager]

EESX - Eastern Exploration Corporation Signs Letter of Intent to Acquire Assets of MAX Entertainment Group SA
Eastern Exploration Corporation (OTCBB:EESX) (“Eastern”), a mineral exploration company, announced today that on May 17, 2007 it signed a Letter of Intent to purchase certain assets of MAX Entertainment Group SA (“MAX”) of Switzerland in an all-stock transaction.

Pursuant to the contemplated transaction, Eastern anticipates that it will, subject to the closing, acquire from MAX its intellectual property, the rights to market MAX’s entertainment and sporting programs in certain European countries, and the trade-marks, trade names, goodwill, contracts, and business associated with these assets (the “Acquired Assets”). In exchange for the Acquired Assets, Eastern shall issue to MAX and/or its shareholders, between 13 and 15 million shares of restricted common stock of Eastern, the final such number to be determined by negotiations between the parties. Eastern will also grant to MAX exclusive licenses to use the Acquired Assets and will assume certain liabilities of MAX.

The contemplated agreement is subject to due diligence being completed to the satisfaction of both Eastern and MAX and to the parties entering into a definitive agreement setting out the full terms of the acquisition. The Letter of Intent may be terminated on 30 day notice by either party.

About MAX

MAX is a Swiss Corporation engaged in the business of promoting and staging Ultimate Fighting-Style Events in Europe. For more information on MAX, interested parties can visit its website, www.maxfighters.com.

MAX stands for Martial Arts X-treme – a new discipline within the martial arts and is to be a development of Ultimate Fighting (USA) or a Mixed Martial Arts. MAX combines different forms of martial arts to create a new discipline. With a view to the anticipated forthcoming events, MAX has issued its own code of rules for MAX combat.

MAX intends to combine MAX style fighting with entertainment, event series, broadcasting in TV and DVD, music, games and the Internet. The key intended business activities are:

MAX event series with national and international championships.
TV broadcasts and reality shows with licenses in many countries in Europe. With the “MAX Martial Arts X-treme” reality series, broadcast on German television during 2006, MAX Entertainment has already begun initiating and producing TV concepts.
The merchandising of MAX’s own products, such as sports drinks, sports and casual clothing, video and DVD, music and computer games.
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products or actions in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.

Eastern Exploration Corporation
Anthony Tai, President and CEO, 778-889-3091
or
MAX Entertainment Group SA
Daniel Kilian, President, [phone]
[e-mail]



Source: Business Wire (May 18, 2007 - 8:00 PM EDT)

News by QuoteMedia
www.quotemedia.com

[Rager]

RBCF - Rubicon Financial Incorporated Announces Acquisition of Minority Interest in Broker/Dealer
Rubicon Financial Incorporated (OTCBB: RBCF) today announced the acquisition of 24.9% of Maximum Financial Investment Group, Inc. (“Maximum Securities”), a NASD licensed broker/dealer.

Maximum Securities offers on-line investors' cutting edge technology, order entry, and top notch customer service. Successful investment and technical professionals formed Maximum Securities to offer one of the most complete and advanced trading systems available.

“Our support staff consists of brokers, traders, and computer experts who can be reached before, during, and after market hours. We believe that real issues deserve real support from real people,” stated Chris Paganes, CEO of Maximum Financial Investment Group, Inc.

RBCF anticipates moving towards the acquisition of the remaining 75.1% ownership of Maximum Securities during fiscal 2007.

“Maximum’s on-line trading platform is anticipated to greatly enhance our business model and this acquisition, although only a minority position, further enhances our ability to provide diversified financial services,” stated RBCF CEO, Joe Mangiapane.

About Rubicon Financial Incorporated:

Rubicon Financial Incorporated is a publicly-traded holding company that intends to acquire private companies in the financial services industry and leverage their strengths within a holding company structure. Rubicon has located its headquarters to the Orange County area of Southern California in order to capitalize on the perceived large and sophisticated customer base located there. The types of financial services Rubicon intends to offer are those of: insurance, both personal and commercial; mortgage and real estate services; retail brokerage services; securities market making; online trading; and investment banking for small to midsized companies. Each segment of these services will be an individual licensed entity under the parent holding company of Rubicon. Rubicon currently has several letters of intent to acquire private companies that it plans to execute in the near future.

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the purchase of the minority interest in Maximum Securities; the size of Maximum Securities and its financial results; the ability of RBCF to execute its business plan and become a diversified financial services company; the ability of RBCF to successfully complete the acquisition of the remaining interest in Maximum Securities; the successful acquisition of other financial services companies; any other effects resulting from the Maximum Securities transaction; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements Rubicon makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the Securities and Exchange Commission. Rubicon undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Rubicon Financial Incorporated
Terry Davis, 949-798-7220



Source: Business Wire (May 17, 2007 - 4:25 PM EDT)

News by QuoteMedia
www.quotemedia.com

[Rager]

RBCF - Rubicon Financial Incorporated Announces Acquisition of Its Second Financial Services Subsidiary
May 17, 2007 9:30:00 AM
Copyright Business Wire 2007
IRVINE, Calif.--(BUSINESS WIRE)--

Rubicon Financial Incorporated (OTCBB: RBCF) today announced that on May 11, 2007 it closed on the acquisition of Rubicon Real Estate and Mortgages, Inc. ("RRE&M"), RBCF's second financial service company acquisition.

RRE&M provides professional assistance in the fields of residential and commercial real estate sales and mortgage loans in California. Mr. Joel Newman is the President of RRE&M and offers 26 years of experience in the real estate field. Further, Mr. Newman has been recognized by RE/MAX as one of the top 1% of real estate brokers nationwide.

In addition to Mr. Newman's expertise, RRE&M has assembled personnel experienced in sales, construction, financing, and management of commercial and residential properties. Being located in Southern California, RRE&M intends to market itself to median and high-end professionals attracted to the area.

"We are extremely optimistic about the immense opportunities within the real estate and mortgage industries. This acquisition allows us to efficiently enter these markets and provided us with an additional $925,000 in cash resources," remarked RBCF CEO, Joe Mangiapane. "This acquisition further solidifies our business model of becoming a diversified, bundled, single-source, financial services boutique within the financial services industry."

RRE&M has designed its business plan to act as modular units that can focus on different aspects of the real estate and mortgages industry. Currently, RRE&M has two modular units specializing in real estate sales and mortgage origination. However, RRE&M anticipates it will also establish modular units of mortgage banking; mortgage and property acquisition; private lending; commercial property sales and loans; broker-owned escrow; and property management as conditions and opportunities warrant it. This type of business plan also allows RRE&M to add or eliminate units without compromising the integrity of the whole company.

"Rubicon Financial's business model is very forward thinking. I am very proud to be a part of the team and excited about the future prospects of the combined companies," stated Joel Newman, President of RRE&M.

About the Acquisition:

The acquisition was accomplished through a reverse triangular merger among RBCF, a wholly owned subsidiary of RBCF, and RRE&M. The agreement and plan of merger provided that the subsidiary merged with and into RRE&M, with RRE&M as the surviving corporation. RBCF issued 1,159,000 shares of its common stock in exchange for 100% of the outstanding securities of RRE&M. Upon the closing of the Merger, RRE&M became a wholly owned subsidiary of RBCF.

A copy of the RRE&M merger agreement was filed as an exhibit to a Form 8-K filed on May 15, 2007, which is currently available through the SEC's website (www.sec.gov). This Form 8-K will be amended within 71 days of the completion of the merger to attach RRE&M's audited financial statements for the period from Inception (April 18, 2007) through April 30, 2007.

About Rubicon Financial Incorporated:

Rubicon Financial Incorporated is a publicly-traded holding company that intends to acquire private companies in the financial services industry and leverage their strengths within a holding company structure. Rubicon has located its headquarters to the Orange County area of Southern California in order to capitalize on the perceived large and sophisticated customer base located there. The types of financial services Rubicon intends to offer are those of: insurance, both personal and commercial; mortgage and real estate services; retail brokerage services; securities market making; online trading; and investment banking for small to midsized companies. Each segment of these services will be an individual licensed entity under the parent holding company of Rubicon. Rubicon currently has several letters of intent to acquire private companies that it plans to execute in the near future.

Forward-Looking Statements:

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the RRE&M acquisition; the size of RRE&M and its financial results; the ability of Rubicon to execute its business plan and become a diversified financial services company; the ability of Rubicon to successfully integrate RRE&M's business into its own; the successful acquisition of other financial services companies; any other effects resulting from the RRE&M acquisition; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated.

Important factors that could cause actual results to differ materially from the forward-looking statements Rubicon makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the Securities and Exchange Commission. Rubicon undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Source: Rubicon Financial Incorporated



----------------------------------------------
Rubicon Financial Incorporated
Terry Davis
949-798-7220

[Rager]

re: P L N I..
if ya have any ? ya can call
Investor Relations
1-866-THE-APPL(E)

(why spni scared me)
though i flipped that burger 3 times

[Rager]

PLNI - Plasticon International, Inc. Voluntarily Files Chapter 11 to Reorganize Company
May 17, 2007 9:08:00 AM
LEXINGTON, KY -- (MARKET WIRE) -- 05/17/07 -- Plasticon International, Inc. (PINKSHEETS: PLNI) announced today that the Company has voluntarily filed for Chapter 11 in order to reorganize Plasticon International, Inc. and its subsidiary, Pro Mold, Inc. Chapter 11 allows a company to reorganize while it continues to operate and grow its business, as opposed to liquidation.

The Company has taken this action in order to safeguard the investment that it has made in Pro Mold, Inc., a subsidiary that the Company bought in December of 2005 for cash and a note totaling $3,500,000. There is currently $875,000 outstanding on the note. Plasticon International, Inc. plans to reorganize the Company under the bankruptcy laws of the United States.

"We felt this action was necessary for Plasticon International, Inc. and its subsidiary, Pro Mold, Inc. We will take this time to reorganize and restructure the Company and we believe that Plasticon will come out from the reorganization in a much stronger position to compete in our industry. We had to take action quickly to defend a precipitous attack from a creditor which had declined to accept a late payment and was apparently interested in seizing control of Pro Mold," stated Jim Turek, CEO and President of Plasticon International, Inc.

About Plasticon International, Inc.:

Plasticon International (www.plasticonintl.com) designs, produces, and distributes high-quality concrete accessories, informational and directional signage and plastic lumber, which are all produced from recycled and recyclable plastics. Plasticon is a leader and an innovator of cutting edge design, engineering, and production of industrial and commercial products. Plasticon is a green company, environmentally friendly, using recycled plastics to produce its line of products.

This press release contains "forward-looking statements." Forward-looking statements are statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, or performance, underlying (expressed or implied) assumptions and other statements that are other than historical facts. These forward-looking statements are only predictions. No assurances can be given that such predictions will prove correct. Actual events or results may differ materially. Forward-looking statements should be read in light of the cautionary statements and risks that include, but are not limited to, the risks associated with a small company, our comparatively limited financial resources, and other factors that may adversely impact us. These or other risks could cause actual results to differ materially from the future results indicated or implied in such forward-looking statements. We undertake no obligation to update or revise such statements to reflect events, circumstances, or new information after the date of this press release or to reflect the occurrence of unanticipated or other subsequent events.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit http://www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.

Contact:
For more information, please visit:
http://www.plasticonintl.com
Or Call:
Investor Relations
1-866-THE-APPL(E)

[Rager]

MKGP - Maverick Energy Group Completed Gas Pipeline in Big Foot Field and Commencement of Natural Gas Sales
May 17, 2007 8:30:00 AM
TULSA, OK -- (MARKET WIRE) -- 05/17/07 -- Maverick Energy Group, LTD (PINKSHEETS: MKGP), a member of Z2, LLC (Z2), is pleased to announce that work on a portion of the refurbished natural gas pipeline system has been completed in the Big Foot Field in Frio County, Texas, where Maverick serves as the operator and is a member of Z2. The pipeline is capable of carrying approximately 500 MCF of gas per day. Maverick also recently started selling natural gas produced in the Big Foot Field.

"We are pleased that construction has been completed on the new natural gas delivery pipeline in the Big Foot Field which enables the Z2 members to conveniently transport the natural gas we are producing directly to the first purchaser. We are already pushing 150 to 200 mcf of gas per day through the new system. That number should steadily climb over the next 90 days or so until we reach full capacity of 500 mcf of gas being sold per day. Coupled with the previously announced increases in producing wells and the expected schedule of as many as 36 new wells operating in Big Foot within a year and their resulting oil and gas, the outlook is extremely bright for Maverick and the other Z2 members," says Jim McCabe, CEO of Maverick Energy Group, LTD.

Maverick announced earlier this month that that oil production in the Big Foot Field had increased from approximately 7,500 barrels of oil per month in August 2006 to in excess of 10,000 barrels of oil per month in March 2007 and it has set a goal of drilling three new puds (wells) per month in the Big Foot Field for the foreseeable future. This increase in production should translate into an additional $1,000,000 to $1,250,000 in revenue per month for Maverick and the Z2 members.

Drilling operations in the Big Foot Field are being funded through a $40,000,000 Advancing Credit Facility which Z2, LLC closed with Gasrock Capital, LLC in August of 2006.

About Maverick Energy Group, LTD

Maverick Energy Group LTD, based in Tulsa, OK, is engaged in the domestic exploration and production of crude oil and natural gas. Its management team has over 150 combined years of experience in the oil & gas and financial services industries. Maverick Energy is the Operator of the "Big Foot Field" in Texas, which was originally developed by Royal Dutch Shell (RDS-A). The Big Foot Field has approximately 300 production wells in the field of which approximately 240 are presently revenue producing. Maverick is also the part owner of several producing natural gas wells and owns additional natural gas leases in West Virginia. The President of Maverick also serves as Chief Financial Officer of Z2, LLC. For more information on Maverick Energy, please visit the company's website at: www.maverickenergygroup.com or www.pinksheets.com.

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; the uncertainty of the oil & gas market; including the geopolitical environment not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Tony Drake
Phoenix IR Associates
281-579-1602
[e-mail]

[Rager]

GERN - Geron Scientists and Collaborators Differentiate Human Embryonic Stem Cells Into Insulin-Producing Islet-Like Clusters
Studies Demonstrate Feasibility of Producing Therapeutic Cells From hESCs for Treatment of Diabetes
May 17, 2007 7:30:00 AM
Copyright Business Wire 2007
MENLO PARK, Calif.--(BUSINESS WIRE)--

Geron Corporation (Nasdaq:GERN) today reported that its scientists and collaborators at the University of Alberta have differentiated human embryonic stem cells (hESCs) into islet-like clusters (ILCs) that secrete insulin in response to elevated glucose levels. The studies demonstrate the feasibility of producing therapeutic cell types from hESCs for the treatment of diabetes.

To be published in the August issue of Stem Cells, which is available now for online viewing in Stem Cells Express at http://stemcells.alphamedpress.org/papbyrecent.dtl, the paper describes studies showing how the researchers differentiated hESCs into cell clusters containing the main cellular components of the islets of Langerhans. The islets of Langerhans are structures in the pancreas that are responsible for regulating and producing insulin in response to changing glucose concentrations and are targets for autoimmune destruction or dysfunction in Type I Diabetes.

"These studies show that the islet-like clusters contain the major cellular components of islets and are sensitive to glucose, the key sugar to which they must respond to be therapeutically beneficial," stated Anish Majumdar, Ph.D., the senior author of the paper. "Our major goal moving forward is to improve the purity, yield and maturational status of these cells to induce normoglycemia in animal models of diabetes."

Geron Corporation was granted U.S. Patent No. 7,033,831 in April 2006 covering the production of insulin-secreting cells from hESCs as well as two U.K. patents covering similar production methods. Geron also has a worldwide exclusive commercial license covering hESC-derived islets from the Wisconsin Alumni Research Foundation.

Geron's scientists and collaborators produced ILCs containing individual cells types that express insulin, glucagon and somatostatin, three of the major hormones produced by islet beta, alpha and delta cells, respectively. Further analysis of the insulin-producing cells indicates they also produce c-peptide, a peptide cleaved upon secretion of the precursor of insulin, indicating that insulin was actually produced, and not absorbed, by the cells. Approximately 2%-8% of the differentiated cells contain insulin and c-peptide and their insulin content was higher than that of fetal islets.

The ILCs functioned to secrete insulin in response to elevated glucose levels. Cells within the ILCs contained secretory granules characteristic of those seen in islet beta cells. In cell culture, the ILCs produced c-peptide and insulin when exposed to higher concentrations of glucose with the kinetics of an immature islet.

The protocol to produce the ILCs drives hESCs through a series of cell culture steps that mimic the progressive differentiation stages during development of the pancreas in humans. Other pancreatic cell types resembling those of the exocrine pancreas were also observed during the differentiation process. The protocol does not utilize serum or feeder cells of any kind, underscoring the scalability of the process.

Originally developed at the University of Alberta, the Edmonton Protocol provides the proof of concept that transplantation of purified cadaveric islets can significantly reduce the need for insulin in patients with advanced Type 1 Diabetes. Problems limiting the accessibility of transplantation therapy for diabetes patients are the poor availability of organs from cadavers and the eventual failure of the grafts, which often require replacement and chronic immunosuppression.

"The Edmonton Protocol provides significant evidence that transplantation of primary islets can be used to successfully reduce the need for insulin in patients with Type 1 Diabetes," said Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer. "It is the work published today that demonstrates the potential of human embryonic stem cells to enable the ready availability of uniform, functional islet cells for therapeutic administration."

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. Geron is also the world leader in the development of human embryonic stem cell-based therapeutics, with its spinal cord injury treatment anticipated to be the first product to enter clinical development. For more information, visit www.geron.com.

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Geron's human embryonic stem cell technology constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Geron's periodic reports, including the quarterly report on Form 10-Q for the quarter ended March 31, 2007.

Source: Geron Corporation



----------------------------------------------
Geron
David L. Greenwood
650-473-7765
Chief Financial Officer
[e-mail]
or
Russo Partners
LLC
David Schull
858-717-2310 (Media)
[e-mail]
Matthew Haines
212-845-4235 (Investors)
[e-mail]

[Rager]

IXOG - Index Oil and Gas Inc.: Serrano First Production
May 17, 2007 7:30:00 AM
2007 PrimeNewswire, Inc.
HOUSTON, May 17, 2007 (PRIME NEWSWIRE) -- Index Oil and Gas, Inc. ("Index", "the Company") (OTCBB:IXOG) today announced that the Company's Serrano gas discovery began producing on 2 May 2007 at a rate of 250 thousand cubic feet of gas per day (MCFGPD).

The shut-in tubing pressure (SITP) and flowing tubing pressure (FTP) were 1,250 pounds per square inch (PSI) of dry gas. Over the first 14 days of production the average production rate was 275 MCFGPD through a 6/64 inch choke.

The Serrano discovery, renamed Friedrich Gas Unit 1, is in Victoria County, Texas. Index has a 37.5% working interest and a 28.125% net revenue interest in this well.

Lyndon West, CEO of Index, commented; "Our relatively large net revenue interest in this successful well will contribute significantly to the Company's cashflow. I look forward to announcing the commencement of further production from recent discoveries in the near future."

About Index

Index is a gas biased oil and gas exploration and production company, with activities in Kansas, Texas, Louisiana, Mississippi and Alabama. It has offices in Houston, Texas and Bath, England. Index is focused on efficiently building a broad portfolio of producing properties with what it believes to be significant upside potential and intends to grow its existing asset base and revenues through further investment in the U.S. The Company seeks to develop its activities in areas containing prolific petroleum systems set in stable political and economic environments.

To find out more about Index Oil and Gas Inc. (OTCBB:IXOG), visit our website at http://www.indexoil.com.

Forward-Looking Statements

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from acquisitions or actions in development are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. Since the information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. Index Oil and Gas Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

CONTACT: Index Oil and Gas Inc.
Lyndon West, CEO
[phone]

[Rager]

EFGO - Esprit Financial Group, Inc. (EFGO) Announces Plans To Meet Pink Sheets Disclosure Categorization
May 17, 2007 6:00:00 AM
LAS VEGAS, May 17 /PRNewswire-FirstCall/ - Esprit Financial Group, Inc. (PINK SHEETS:EFGO.PK) announced today that it has begun the process of becoming a Pink Sheets Disclosure Categorization compliant company which Pink Sheets is scheduled to begin in August 2007 http://www.pinksheets.com/about/pr_042407.jsp

"Esprit management sees this as an opportunity to allow it to have a greater investor audience, further its strategic goals and enhance shareholder value," says Garr Winters, CEO of Esprit. "We have the infrastructure in place to make this move and I believe it is an important step for us to take as we begin to execute the early phase of our strategic business plan. Pink Sheets has instituted this disclosure categorization policy and we want EFGO to be one of the first companies to meet these guidelines. Our legal department has already began compiling relevant data that we will upload to the pink sheet site as soon as it is compiled well ahead of the August 2007 deadline so that this information will be made available to the public and our shareholders."

Esprit has always desired to remain fully reporting, although past circumstance made this impossible with the business interuptions in 2005. The Company has subsequently taken extraordinary steps to remain transaparent in its activities to ensure shareholders and other stakeholders were well informed of the Company's activities.

As Esprit continues to roll-out its new international financial service products, particularly in the Advanced Electronics Funds Management and Forex Trading divisions, Esprit will increase its profile within the financial community, both for financial services as well as retail investors. Becoming fully compliant will reinforce the Company's credibility and enhance its reputation.

This immediate initiative is a first step as far as becoming fully reporting and participating in the top tier of the Pink Sheets OTC market.

About Esprit Financial Group Inc.

Esprit Financial Group Inc, is a public company engaged in a diversified number of online financial services.

PayDay Loans: The Company is a pioneer in the payday loan industry, and continues to develop the most comprehensive menu of services in the cash advance industry and will retain the Cash Now brand for many of these services. Operations include licensing of a comprehensive suite of Internet-based payday loan and check cashing software and private label back end office systems for the sub prime market, under the Cash Now banner www.cashnow.org. The Company also operates www.cashnow.net, which generates leads of consumers looking for payday loans on behalf of our licensees. The company's proven business model comprises operations in the U.S. and Canadian markets as well as several foreign markets. Additionally, the Company's website is the most advanced payday-lending portal, offering key insight to clients and potential clients alike.

Forex: Additionally, the Company's Forex Trading division offers an innovative low-cost online Forex trading service at www.cashnow.com. The Company acts as an Introducing Broker for Advanced Markets, Inc., and is targeted to serious day traders. All transactions are handled on a streaming pass-through basis. There is no trading desk, and no manipulation of quotes that lag the actual interbank market. Importantly, traders can continue to trade actively even during volatile periods that result from major news events of publishing of market reports.

Advanced Electronic Funds Management: The Company's Advanced Electronic Funds Management (AEFM) division offers Cash Now Check 21 - an advanced checking clearing service that can significantly reduced holdback periods by banking institutions, particularly valuable for international markets. Its EM2 (Electronic Money Management System) product is a comprehensive e-wallet capable of managing multiple bank accounts, remitting funds worldwide and provide banking capabilities to consumers without requiring that they have a bank account.

Structured Debt Resolution: This division will offer services that allow banks, financial institutions and other creditors to invite defaulted clients to negotiate a settlement online, in a neutral and non-confrontational manner, bypassing traditional collection calls and mail delivered notices of default.

Safe Harbor Statement

Information in this press release may contain 'forward-looking statements.' Statements describing objectives or goals or the Company's future plans are also forward-looking statements and are subject to risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those anticipated. Forward-looking statements in this news release are made pursuant to the 'Safe Harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to sales, continued acceptance of Esprit Financial Group's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Esprit Financial Group's periodic reports filed with the regulatory authorities.

SOURCE Esprit Financial Group



----------------------------------------------
Esprit Financial Group Inc.
[e-mail]
Investor Relations: [phone]

[Rager]

EAGB - Eagle Broadband Ships SatMAX(R) Alpha System for a Classified US Government Program
May 17, 2007 7:30:00 AM
Copyright Business Wire 2007
LEAGUE CITY, Texas--(BUSINESS WIRE)--

Eagle Broadband, Inc. (OTCBB: EAGB), a leading national provider of IPTV products and services, today announced that the company has shipped another SatMAX Alpha Emergency Communication System for use in a classified U.S. Government program. This marks the sixteenth SatMAX system that Eagle has shipped and the sixth Alpha ECS in the past seven months for government programs.

Typically utilized for its emergency communications capabilities, Eagle's SatMAX technology is also a highly effective tool for testing all types of Iridium-based technology. The Alpha ECS unit, a "SatMAX-in-a-suitcase", is highly portable and permits establishment of an emergency response center in almost any enclosed area. The SatMAX system permits non-line-of-sight use of Iridium satellite phones. Thus, control centers can be in touch with units in the field and in fact make a call to any telephone worldwide.

"With another severe hurricane season forecast, we are finding a lot of interest in our successful SatMAX products, in both the portable Alpha ECS units and the fixed-rack units," said Dave Micek, president and CEO of Eagle Broadband. "This order for a U.S. Government program yet again validates the application of our SatMAX products for military and government organizations worldwide. As many know, these organizations typically require anonymity given the nature of their programs, so we are unable to provide customer details, though we look forward to continued orders."

A recently released, three-minute video explaining the full range of the features and capabilities of Eagle's SatMAX products can be found at www.impactmovie.com/eaglebroadband.

About Eagle Broadband, Inc.

Eagle Broadband is a leading national provider of IPTV products and services through its two core divisions:

IPTV -- Eagle Broadband's IPTVComplete(TM) provides direct access to more than 250 channels of high-demand programming from popular entertainment providers, often using Eagle's high-definition, set-top boxes.

IT Services - Eagle Broadband's IT Services Group is a full-service integrator offering a complete range of network technology products including VoIP, remote network management, network implementation services and IT project management services. This division also includes Eagle's SatMAX(R) product offering which provides indoor/outdoor communications via Iridium's (www.iridium.com) global satellite communications system. The SatMAX system offers both fixed and mobile solutions, including the Alpha emergency first responder "SatMAX-in-a-suitcase" technology.

For more information on Eagle Broadband, visit www.eaglebroadband.com.

EAGB-G

EAGG
Forward-looking statements in this release regarding Eagle Broadband, Inc., are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, the company's ability to continue as a going concern, the company's liquidity constraints and ability to obtain financing and working capital on favorable terms, the continued acceptance of the company's products, increased levels of competition, new products and technological changes, the company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

Source: Eagle Broadband, Inc.



----------------------------------------------
CWR & Partners
Kelly Cinelli or Veronica Welch
508-222-4802

[Rager]

MBKR - MortgageBrokers.com Signs New Revenue Licensing Agreement with Sergio Barboza and Associates Worth an Estimated CAD$50 Million in Mortgage Origination
May 17, 2007 7:30:00 AM
TORONTO, May 17 /CNW/ - MortgageBrokers.com Holdings Inc. (OTC BB: MBKR) announced today that it has signed an exclusive revenue licensing agreement with veteran mortgage specialist, Sergio Barboza and Associates led by Mr. Sergio Barboza formerly of Royal Bank of Canada. Mr. Barboza and his team are expected to generate in excess of CAD$50 million in mortgage origination for 2007. This figure is based on the individual financial history of Mr. Barboza and the current financial trends affecting the markets in which they operate. Sergio Barboza and Associates will operate exclusively under the MortgageBrokers.com brand and share a percentage of their net profits with the Company.


This news follows a series of press releases from MortgageBrokers.com announcing the signing of revenue sharing agreements with numerous mortgage brokerages and individuals that will continue to generate revenue for the company.


Mr. Barboza will be servicing the Greater Toronto Area, the largest metropolitan city in Canada and will be participating in the RE/MAX co-location program. The strategic alliance partnership between MortgageBrokers.com and RE/MAX allows the company the opportunity to access up to an estimated CAD$32 billion in real estate sales transactions for 2007.


"Mr. Barboza is an important addition to our team, and this sends a definite alert to the industry that our business model and strategic alliance partnerships are strong incentives that attract quality mortgage brokers," said Alex Haditaghi Founder and CEO of MortgageBrokers.com.


"Leaving the confines of a large financial institution to join in the vision of MortgageBrokers.com was an easy decision," said Mr. Barboza, Business Partner. "Aligning yourself with a real estate brand like RE/MAX and to those closest to customer referrals is the future direction of the industry, I am pleased to be part of it," continued Mr. Barboza.


About MortgageBrokers.com


MortgageBrokers.com is an online lead generator and mortgage brand specializing in the mortgage brokerage sector. The Company is dedicated to re-branding the over 40,000 small and medium mortgage broker (SME) firms in North America while providing these entities scalability through a centralized shared services platform. MortgageBrokers.com is designed to facilitate continued ownership for these SME brokers while they work under the umbrella of one globally recognized brand. The Company provides centralized services in the areas of payroll and accounting, compliance, marketing, technology, HR and lead generation to afford our brokers improved access to potential customers through strategic alliances and partnerships. MortgageBrokers.com also provides its national team the opportunity to leverage origination with lending institutions, establish higher referral fees from lenders, and give its team members the ability to earn ownership in a publicly-traded entity with the goal of an eventual career exit strategy.


Further information can be found at www.mortgagebrokers.com.


About RE/MAX


RE/MAX is Canada's leading real estate organization with CAD$32 billion in sales and over 15,600 sales associates in more than 610 independently-owned and operated offices. The RE/MAX franchise network, now in its 33rd year of consecutive growth, is a global real estate system operating in over 62 countries. More than 6,000 independently-owned offices engage over 114,000 member sales associates who lead the industry in professional designations, experience and production, while providing real estate services in residential, commercial, referral, relocation and asset management.


Cautionary Note Regarding Forward-Looking Statements


Statements included in this press release, which are not historical in nature, are intended to be, and are hereby identified as 'Forward-Looking Statements' for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including 'anticipate,' 'await,' 'envision,' 'foresee,' 'aim at,' 'plans,' 'believe,' 'intends,' 'estimates,' 'expects' and 'projects' including without limitation, those relating to the company's future business prospects, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations. www.sec.gov



----------------------------------------------
Cervelle Group Investor Relations: Rob Karbowsky
407-475-9966 [e-mail] or Public Relations: David Donlin
407-475-9966 [e-mail]

[Churak]

OXBDF - Oxford Biomedica Plc announces Phase II Date at AAI Meeting
Thursday May 17, 2:01 am ET


OXFORD, UK--(MARKET WIRE)--May 17, 2007 --


For Immediate Release 17 MAY 2007


OXFORD BIOMEDICA ANNOUNCES THAT PHASE II RESULTS WITH HI-8(R)
MEL IN MELANOMA WILL BE PRESENTED AT AMERICAN ASSOCIATION
OF IMMUNOLOGISTS MEETING

Oxford, UK: 17 May 2007: Oxford BioMedica (LSE:OXB.L - News), the leading gene therapy company, today announces that scientists from its wholly owned subsidiary, Oxxon Therapeutics, and its clinical collaborators will present results from a Phase II trial of Hi-8 MEL in melanoma at the American Association of Immunologists (AAI) Annual Meeting, to be held on 18-22 May in Miami, Florida. The abstract has been selected for both an oral and a poster presentation.

ADVERTISEMENT


The presentation will include updated data from the completed Phase II trial of Hi-8 MEL in 41 patients with Stage III/IV melanoma, which was conducted at multiple sites in the UK and Germany. The trial was designed to evaluate the immune and clinical responses elicited by the prime-boost immunotherapeutic vaccine, Hi-8 MEL. The product consists of a recombinant DNA vaccine and modified vaccinia virus Ankara (MVA), both of which have been engineered to contain DNA that encodes a string of seven cytotoxic T-cell epitopes from five melanoma antigens.

The presentation will include further follow-up of a patient that exhibited both a sustained partial clinical response (tumour shrinkage) and also a strong antigen-specific immune response following treatment. In addition, the presentation will highlight previously reported data on immunogenicity and clinical benefit. The product was highly immunogenic with 91% of patients that received the optimal dose showing an antigen-specific immune response. In terms of clinical benefit, eight patients (20%) showed disease control, including the patient with a partial response and an additional seven patients with periods of stable disease. The median survival for immune responders was 100 weeks versus 37 weeks for non-responders (p<0.001). Details of the presentations are as follows:

Title: Induction of antigen-specific CD8+ T cells in melanoma patients using a prime-boost therapeutic vaccine (Abstract #48.18).




Poster Presentation

Session: Tumour-Associated Antigens/Cancer Vaccines Immunotherapy.

Date and location: Saturday, 19 May 2007, 7:30 AM-6:00 PM, Miami Beach
Convention Center, Exhibit Hall B.

Oral Presentation

Session: Tumour-Associated Antigens and Cancer Vaccines.

Date and Location: Sunday, 20 May 2007, 11.45 AM-12.15 PM, Miami Beach
Convention Center, Room A101/102


The abstract may be accessed online at http://www.immunology2007.org.

-Ends-

For further information, please contact:
Oxford BioMedica plc: Tel: [phone]

Professor Alan Kingsman, Chief Executive
City/Financial Enquiries: Tel: [phone]

Lisa Baderoon/ Mark Court/ Mary-Jane Johnson Buchanan
Communications
Scientific/Trade Press Enquiries: Tel: [phone]

Gemma Price/ Holly Griffiths/ Katja Stout
Northbank Communications

Notes to editors

1. Oxford BioMedica

Oxford BioMedica (LSE:OXB.L - News) is a biopharmaceutical company specialising in the development and commercialisation of novel therapeutic vaccines and gene-based therapies with a focus on oncology and neurotherapy. The Company was established in 1995 as a spin-out from Oxford University, and is listed on the London Stock Exchange.

The Company has a platform of gene delivery technologies, which are based on highly engineered viral systems. Oxford BioMedica also has in-house clinical, regulatory and manufacturing know-how. In oncology, the lead product candidate is TroVax®, an immunotherapy for multiple solid cancers, which is licensed to Sanofi-Aventis for global development and commercialisation. A Phase III trial of TroVax in renal cancer is ongoing and Sanofi-Aventis is implementing a development plan for colorectal cancer. Oxford BioMedica's oncology pipeline includes a specific immunotherapy candidate, Hi-8® MEL, for melanoma, which has completed two clinical trials. In neurotherapy, the Company's lead product, ProSavin®, is expected to enter clinical development for Parkinson's disease in 2007. The neurotherapy pipeline also includes preclinical gene-based therapeutics for vision loss, motor neuron disease and nerve repair. In addition, the Company has a platform technology for therapeutic vaccines for infectious diseases.

The Company is underpinned by over 80 patent families, which represent one of the broadest patent estates in the field. The Company has a staff of approximately 75 split between its main facilities in Oxford and its wholly owned subsidiary, BioMedica Inc, in San Diego, California. Corporate partners include Sanofi-Aventis for TroVax and Wyeth for a targeted antibody therapy. The Company also has collaborations with Intervet, Sigma-Aldrich, Viragen, MolMed and Virxsys. Technology licensees include Merck & Co, Biogen Idec, GlaxoSmithKline and Pfizer.

Further information is available at www.oxfordbiomedica.co.uk

2. Hi-8® MEL

Hi-8 MEL is Oxford BioMedica's therapeutic vaccine for metastatic melanoma. The product consists of two recombinant vectors, a plasmid DNA and a non-replicating Modified Vaccinia Ankara (MVA) virus. Both vectors encode the Mel3 polyepitope string derived from five different melanoma-associated antigens. Administration of the two recombinant vectors in a heterologous prime-boost format is designed to induce broad melanoma-specific CD8+ T-cell responses. All clinical endpoints have been achieved in two completed clinical trials, which included a Phase II dose-selection study in 41 patients with non-resectable, Stage III/IV melanoma. Melanoma comprises just 5% of all skin cancers but it is the most deadly. It is the seventh most common cancer in the USA. Median survival is less than one year for Stage IV disease and less than five years for Stage III disease. The total treatment market for melanoma is forecast to be in excess of US$775 million by 2010 (Datamonitor).




This information is provided by RNS
The company news service from the London Stock Exchange



Contact:


--------------------------------------------------------------------------------
Source: Oxford Biomedica Plc

[100lbStriper]

its exploding !!! to da moon !!! lol !!! get some baby !!!

[Rager]

CLRXQ to CLRX C S T Entertainment Inc Common Stock Bankruptcy plan was closed on 5/23/2001 with no impact on common shareholders **

[Rager]

have to, tried choice trades..they are not registered in my neck of the woods.

[Churak]

have you checked out PRODIGY or INTERACTIVE BROKERS?

[Rager]

TDA's legacy


High Call Volume
We are currently experiencing a high volume of phone calls. We ask for your patience, and are working to resolve this as quickly as possible. Meanwhile, please consider contacting us by e-mail (go to Contact Us, under Client Services).

well imo if they stopped using the greed mongers SBSH
it would cut the calls in half

they suck since the merger with TDwaterhose
had an RJT account once, they merged with TD
same crap

looking for a new broker...!

[100lbStriper]

ok cool, your on !

[Rager]

yucko on the veggy...cup a coffee sounds good though